Clinical Trial Update: A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131). [Phase 3]

View source ↗

Summary

Phase III randomized trial to evaluate non-inferiority of immunogenicity and safety of Hillchol (BBV131) to Shanchol, plus lot-to-lot consistency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Hillchol (BBV131)
• Shanchol (oral cholera vaccine)

Snippet

Sponsor: Bharat Biotech International Limited | Conditions: Cholera | Phase 3 | Status: UNKNOWN